Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells.

[1]  Jill A. Livengood,et al.  Genetic and Phenotypic Characterization of Manufacturing Seeds for a Tetravalent Dengue Vaccine (DENVax) , 2013, PLoS neglected tropical diseases.

[2]  N. Nomura,et al.  Sulfated Polysaccharide, Curdlan Sulfate, Efficiently Prevents Entry/Fusion and Restricts Antibody-Dependent Enhancement of Dengue Virus Infection In Vitro: A Possible Candidate for Clinical Application , 2013, PLoS neglected tropical diseases.

[3]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[4]  E. Damonte,et al.  Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides. , 2012, International journal of biological macromolecules.

[5]  E. Damonte,et al.  Differential Requirements in Endocytic Trafficking for Penetration of Dengue Virus , 2012, PloS one.

[6]  S. Sekaran,et al.  RNA Interference Mediated Inhibition of Dengue Virus Multiplication and Entry in HepG2 Cells , 2012, PLoS ONE.

[7]  Betty A. Wu-Hsieh,et al.  Dengue Type 4 Live-Attenuated Vaccine Viruses Passaged in Vero Cells Affect Genetic Stability and Dengue-Induced Hemorrhaging in Mice , 2011, PloS one.

[8]  E. Mackow,et al.  Productive Dengue Virus Infection of Human Endothelial Cells Is Directed by Heparan Sulfate-Containing Proteoglycan Receptors , 2011, Journal of Virology.

[9]  Rosanna W. Peeling,et al.  Dengue: a continuing global threat , 2010, Nature Reviews Microbiology.

[10]  J. Chu,et al.  Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus , 2010, Virology Journal.

[11]  A. D. de Silva,et al.  N-linked glycans on dengue viruses grown in mammalian and insect cells. , 2009, The Journal of general virology.

[12]  G. Áñez,et al.  Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques , 2009, Journal of Virology.

[13]  E. Damonte,et al.  Alternative infectious entry pathways for dengue virus serotypes into mammalian cells , 2009, Cellular microbiology.

[14]  Michael J Rust,et al.  Dissecting the Cell Entry Pathway of Dengue Virus by Single-Particle Tracking in Living Cells , 2008, PLoS pathogens.

[15]  Takashi Suzuki,et al.  Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. , 2008, Biochemical and biophysical research communications.

[16]  R. D. del Ángel,et al.  Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT. , 2008, Virology.

[17]  Tyler R. Prestwood,et al.  A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral Loads , 2008, Journal of Virology.

[18]  E. Damonte,et al.  Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis. , 2008, The Journal of general virology.

[19]  E. Damonte,et al.  Interference in dengue virus adsorption and uncoating by carrageenans. , 2007, Virology.

[20]  H. Agaisse,et al.  Rab 5 Is Required for the Cellular Entry of Dengue and West Nile Viruses , 2007, Journal of Virology.

[21]  A. Davidson,et al.  Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination. , 2006, The Journal of general virology.

[22]  B. Guy,et al.  Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3). , 2006, Vaccine.

[23]  E. Damonte,et al.  The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. , 2005, Antiviral research.

[24]  Yee‐Shin Lin,et al.  Heparin inhibits dengue-2 virus infection of five human liver cell lines. , 2002, Antiviral research.

[25]  H. Lortat-Jacob,et al.  Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. , 2002, Virology.

[26]  P. Hilgard,et al.  Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes , 2000, Hepatology.

[27]  A. Dautry‐Varsat,et al.  Inhibition of clathrin-coated pit assembly by an Eps15 mutant. , 1999, Journal of cell science.

[28]  S. Schmid,et al.  AP-2/Eps15 Interaction Is Required for Receptor-mediated Endocytosis , 1998, The Journal of cell biology.

[29]  S. Schmid,et al.  AP-2 / Eps 15 Interaction Is Required for Receptor-mediated Endocytosis , 1998 .

[30]  J. Esko,et al.  Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate , 1997, Nature Medicine.

[31]  R. G. Anderson,et al.  Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation , 1993, The Journal of cell biology.